DataXstream Expands into EMEA and Announces New President
6.6.2024 15:37:00 EEST | Business Wire | Press release
DataXstream LLC, an SAP® Endorsed app and Gold-level partner dedicated to building solutions on emerging technologies for SAP users in sales and distribution, today announced its European expansion with the opening of its EMEA office in Barcelona, Spain and the appointment of Jean-Jérôme (JJ) Peytavi as President of DataXstream EMEA. A multi-cultural executive with a deep understanding of the nuances in global business, Peytavi will work with regional DataXstream partners, as well as with SAP teams across Europe, to bring solutions to B2B customers that are struggling with complex sales and order management needs.
“JJ’s proven track record for developing strategies and solutions that meet complex customer needs, as well as his diverse background and effective leadership across many industries make him ideally suited to take DataXstream to this next level,” said Tim Yates, chief executive officer for DataXstream. “Opening the EMEA office is an exciting milestone for the company, and I am thrilled to have JJ lead this effort.”
This expansion is in response to the growing global demand for more efficient, streamlined order management solutions, especially within SAP environments. Customers worldwide seek seamless purchasing experiences across multiple sales channels. B2B organizations are now tasked with selling across numerous sales channels while deploying multiple solutions to handle industry needs like customer specific pricing, shipping options, credit card capabilities, rental capabilities, wallet share and more—all of which must be integrated into their ERP system. Consequently, many organizations now experience inefficiencies in their sales processes. These inefficiencies cause potential errors and delays at every touchpoint, frustrating both employees and customers, and can impede future modernization efforts.
“There is a significant need for B2B organizations to invest in a more efficient, future-ready platform that can seamlessly integrate all of these disparate channels and deliver real-time visibility into sales orders, product availability, customer information, and more,” said JJ Peytavi, president of DataXstream EMEA. “DataXstream’s OMS+ cross-channel order management platform solves this complexity by integrating all the data, from all the sales channels, into a single platform so that each channel delivers a consistent experience to the end customer. Opening the EMEA office demonstrates our commitment to serving SAP customers in Europe who are struggling with these complex sales order management issues, and I look forward to leading this effort.”
About DataXstream
DataXstream is an SAP® Gold and Endorsed App Partner dedicated to building solutions on emerging technologies that maximize the ROI of our customers’ SAP® infrastructure. As members of the SAP® marketplace, DataXstream’s products can be found in the SAP® Store. Your company is already running the most powerful ERP solution; empower your employees with DataXstream’s OMS+ to take your organization’s sale and customer buying experience to new levels.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240606654898/en/
Contact information
Cailin Yates
Chief Marketing Officer
757.345.3437
cyates@dataxstream.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom